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MICA Engagement by Human V2V2 T Cells Enhances
Their Antigen-Dependent Effector Function
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Most human  T cells express on their cell surfaceSummary
an activating NKG2D molecule having a short cyto-
plasmic tail noncovalently associated with DAP10, anV2V2 T cells comprise 2%–5% of human peripheral
blood T cells, recognize ubiquitous nonpeptide anti- adaptor molecule that enables signal transduction (Wu
et al., 1999; Bauer et al., 1999). The ligands for thisgens, and expand up to 50-fold during microbial infec-
tion. It is not clear why these V2V2 T cells expand activating receptor are MHC class I-related chains (MIC)
A and B, which are allelic, polymorphic molecules thatonly after microbial infection. We show here that the
stress-inducible molecule, MICA, is induced on the have three extracellular domains, a transmembrane do-
main, a cytoplasmic domain, and lack an associationsurface of dendritic and epithelial cells by infection
with M. tuberculosis in vitro and in vivo. MICA engage- with 2 microglobulin. MICA is preserved in most mam-
mals except for rodents and is present at high levels inment by the activating receptor, NKG2D, present on
V2V2 T cells, resulted in a substantial enhancement gastrointestinal epithelium and on tumor cells of epithe-
lial origin (Groh et al., 1999). MICA is induced to highof the TCR-dependent V2V2 T cell response to non-
peptide antigens and protein superantigens alike. cell surface levels by heat shock and thus may be under
control of heat shock promoter elements (Groh et al.,Thus, a MICA-NKG2D interaction may be necessary
for an effective innate immune response to microbe- 1996). Human NK cells and V1 T cells bearing NKG2D
receptors can lyse tumor cells bearing MICA and targetassociated antigens that also are constitutively pres-
ent in vivo. cells transfected with MICA genes, and this lysis can
be blocked using antibodies to MICA or NKG2D (Bauer
et al., 1999; Groh et al., 1998). However, little is knownIntroduction
about the role of NKG2D in the activation of nonpeptide
antigen-reactive V2V2 T cells in response to microbialV2V2 T cells are likely to play an important role in host
defense and immunoregulation. Found only in primates, infection.
these V2V2 T cells expand significantly in vivo during Levels of surface MHC class I molecules are fre-
a variety of infectious diseases such as tuberculosis quently lower than normal in virus-infected or tumor
(14%) (Balbi et al., 1993), salmonellosis (18%) (Hara et cells, which results in their decreased engagement by
al., 1992), leishmaniasis (13%) (Raziuddin et al., 1992), inhibitory NK cell receptors and thus activation of NK
erlichiosis (57%) (Caldwell et al., 1996), brucellosis (29%) cells (Lanier, 1998; Karre et al., 1986; Collins et al., 1998;
(Bertotto et al., 1993), tularemia (31%) (Sumida et al., Halary et al., 1997). Thus, steady levels of surface MHC
1992), listeriosis (12%) (Munk et al., 1990), toxoplasmo- class I expression indicates cell integrity, resulting in
sis (9%) (Scalise et al., 1992), malaria (11%–16%) (Perera protection against NK cell attack. In contrast, increased
et al., 1994), and HIV (8%) (De Maria et al., 1992). Recent surface expression of MICA or MICB may signal cellular
insights into antigen recognition by  T cells have fo- distress and evoke immune responses. We show here
cused on the immunoglobulin-like structure of the  that bacterial infection upregulates MICA expression on
TCR (Li et al., 1998) and on recognition of small organic cell surfaces, thus enhancing TCR-dependent activation
phosphate molecules (Tanaka et al., 1994, 1995), amino- of V2V2 T cells by nonpeptide antigens that may then
provide an innate immune response to bacterial infec-
tion in vivo.4 Correspondence: jbukowski@rics.bwh.harvard.edu
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Figure 1. Comparison of C1R Mock and C1R MICA as Targets for Antigen-Dependent Lysis Mediated by the V2V2 T Cell Clone Isoamyl
5.C7 and Blocking of Specific Lysis of C1R MICA Targets by Anti-MICA/B and Anti-NKG2D mAbs
(A) Cytotoxicity against C1R MICA transfectant or C1R mock in the presence or absence of sec-butylamine (SBA) by the V2V2 T cell clone
isoamyl 5.C7.
(B) Cytotoxicity against untransfected Daudi cells or the Daudi MICA transfectant by the V2V2 T cell clone isoamyl 5.C7.
(C) Cytotoxicity of V2V2 T cell clone isoamyl 5.C7 against C1R MICA targets in presence of sec-butylamine (SBA) was blocked by anti-
MICA/B 6D4 mAb F(ab)2 but not by an isotype-matched control mAb.
(D) Cytotoxicity of NKL against C1R MICA targets was blocked with 6D4 F(ab)2 but not by an isotype-matched control mAb. Sec-butylamine
(SBA) did not augment the killing mediated by NKL.
(E) Cytotoxicity of V2V2 T cell clone isoamyl 5.C7 against C1R MICA targets in the presence of sec-butylamine was blocked with anti-
NKG2D mAbs 5C6 and 1D11 but not by an isotype-matched control mAb.
Results antigen sec-butylamine, C1R MICA targets were lysed
2-fold more efficiently than C1R mock targets by the
V2V2 T cell clone isoamyl 5.C7 (Figure 1A). Daudi cellsMICA Enhanced Cytotoxic Activity of a V2V2 T Cell
Clone in Response to Antigenic Stimuli express endogenous antigens that are recognized by
V2V2 but not V1V1 TCRs (Bukowski et al., 1995).To examine the effect of MICA on the antigen-dependent
lytic response of V2V2 T cells, we compared the sensi- As such, Daudi cells that lack surface MICA expression
were lysed by V2V2 T cells to a significant degree intivity to lysis of the lymphoblastoid cell line C1R stably
transfected with MICA (C1R MICA) to that of mock- the absence of added antigen (Figure 1B). However,
Daudi cells transfected with MICA were up to 15 timestransfected C1R (C1R mock). In the absence of antigen,
there was no significant killing of either C1R mock or more sensitive to lysis by the V2V2 T cell clone isoamyl
5.C7 as compared to mock-transfected Daudi cells (Fig-C1R MICA. However, in the presence of the nonpeptide
MICA-NKG2D Interaction in Human V2V2 T Cells
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Figure 2. Three Distinct Antigen Types Were Used to Induce IL-2 Release from Clone Isoamyl 5.C7 in a Dose-Dependent Manner Using the
C1R MICA Transfectant or the C1R Mock Transfectant as Accessory Cells
(A) 100 M pamidronate (aminobisphosphonate), (B) 1:40 M. tuberculosis extract (containing phosphate antigens), and (C) 1 g/ml staphylococ-
cal enterotoxin A (SEA, a protein superantigen) were serially diluted and used to stimulate isoamyl 5.C7 in presence of equal numbers of
mitomycin-C-treated C1R MICA transfectants (closed squares) or C1R mock transfectants (open squares) as accessory cells.
ure 1B). Thus, the presence of surface MICA on target tuberculosis containing phosphate antigens (Morita et
cells is not sufficient to sensitize target cells to lysis al., 1995) and pamidronate (an aminobisphosphonate)
by V2V2 T cells, nor is surface MICA required for (Kunzmann et al., 1999) without MHC or CD1 restriction.
nonpeptide antigen-specific lysis of target cells by In addition, these V2V2 T cells recognize the superan-
V2V2 T cells. These results suggest that MICA is a tigen staphylococcal enterotoxin A (SEA) in an MHC
ligand that can sensitize target cells to enhanced lysis class II-dependent manner (Rust et al., 1990). To exam-
by V2V2 T cells in the presence of antigen. ine the effect of MICA expression on the V2V2 T cell-
To more definitively determine if the interaction be- mediated cytokine responses to distinct classes of anti-
tween MICA on the target cells and its receptor NKG2D gens, we performed cytokine release assays using the
on the effector cells was important for enhanced lysis, NKG2DV2V2 T cell clone isoamyl 5.C7 as an effector,
we included the anti-MICA/B mAb, 6D4, or the anti- C1R mock or C1R MICA as accessory cells, and the
NKG2D mAbs, 1D11 and 5C6, in the cytotoxicity assays. three different antigenic stimuli described above. Com-
As before, V2V2 T cells did not significantly kill C1R pared to C1R mock, C1R MICA as an accessory cell
MICA targets in the absence of antigen. However, pre- resulted in a 3- to 10-fold decrease in the amount of
treatment of C1R MICA targets with anti-MICA but not antigen needed to achieve equivalent levels of IL-2 re-
with an isotype control mAb reduced the sec-butylamine lease, using phosphate antigens included in an M. tuber-
antigen-dependent V2V2 T cell-mediated killing by culosis extract (Figure 2A), pamidronate (Figure 2B), or
5-fold, compared to untreated targets (Figure 1C). Con- the protein superantigen SEA (Figure 2C) as antigenic
sistent with previous data (Bauer et al., 1999) and in stimuli. Again, there was no detectable IL-2 release in
contrast to experiments using resting V2V2 T cells as the absence of antigen, using either C1R mock or C1R
effectors, the NK cell line, NKL, killed C1R MICA targets MICA as accessory cells. These results show that inter-
equally well in the presence or absence of the sec- action with MICA can enhance V2V2 T cell-mediated
butylamine antigen, and this killing was blocked by anti- cytokine responses to nonpeptide antigens and to con-
MICA but not by an isotype control mAb (Figure 1D). In ventional protein superantigens.
addition, cytotoxicity mediated by the V2V2 T cell We next compared eight NKG2D V2V2 T cell
clone isoamyl 5.C7 was only partially blocked using anti- clones raised against a variety of nonpeptide alkylamine
NKG2D mAbs 1D11 and 5C6 (Figure 1E). This partial and alkyl phosphate antigens for their reactivity to anti-
blocking seen in many experiments reflects the fact that gen using either C1R mock or C1R MICA. Most V2V2
the presence of surface MICA on target cells is not T cell clones recognize a panel of nonpeptide antigens in
absolutely required for antigen-dependent lysis by a hierarchical way that depends on antigenic “strength,”
V2V2 T cells (Figures 1A and 1B). These experiments without regard to which antigen was used to derive
show that the interaction between NKG2D on V2V2 the clone (Tanaka et al., 1994). Ethylamine and sec-
T cells and MICA on target cells augments antigen- butylamine are weak and strong antigens for V2V2 T
dependent target cell killing. cells, respectively. Three representative clones, isoamyl
5.C7 (Figures 3A and 3B), MEP 25.B3 (Figures 3C and
3D), and n-propyl 25.H5 (Figures 3E and 3F), requiredMICA Enhanced Cytokine Release by V2V2 T Cell
2- to 10-fold less sec-butylamine for a comparable levelClones in Response to Antigenic Stimuli
of IL-2 or IFN- release when using C1R MICA accessoryV2V2 T cell clones require accessory cells for optimal
cytokine responses and recognize extracts from M. cells as compared to C1R mock cells. None of these
Immunity
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Figure 3. Antigen-Dependent Cytokine Release by Three Different V2V2 T Cell Clones in the Presence of the C1R MICA Transfectant as
Compared to the C1R Mock Transfectant as Accessory Cells
The release of IL-2 or IFN- in response to serial dilutions of sec-butylamine (triangles) and ethylamine (squares) at 25 mM initial concentrations
by V2V2 T cell clones isoamyl 5.C7 (A and B) MEP 25.B3 (C and D) and n-propyl 25.H5 (E and F) using equal numbers of mitomycin-C
treated C1R MICA transfectants (closed symbols) or C1R mock transfectants (open symbols) as accessory cells. The decreased amounts of
IL-2 or IFN- released at high antigen doses were due to toxicity.
NKG2D T cell clones responded in the absence of anti- We have previously shown that cotransfection of
gen. In some instances, there was no detectable IL-2 TCR Jurkat recipient cells with cDNAs specifying TCR
or IFN- release in response to the weak antigen ethy- V2 and TCR V2 but not TCR V1 and TCR V1 confers
lamine using C1R mock accessory cells. Inclusion of upon these recipient cells the ability to release IL-2 in
C1R MICA as accessory cells resulted in detectable response to nonpeptide alkylamine and organophos-
IL-2 and IFN- responses to ethylamine. These results phate antigens. Reactivity to these nonpeptide antigens
suggest that interaction with MICA may be required for is thus V2V2 TCR dependent (Bukowski et al., 1995,
antigen-specific V2V2 T cell responses when antigens 1999; Tanaka et al., 1995).
are limited in concentration or are of low potency. To analyze the relative roles of NKG2D and the V2V2
TCR in the recognition of MICA, we used the native
NKG2D V2V2 T cell clone DG.SF13 and the NKG2DMICA Failed to Enhance the Response to Antigen
V2V2 TCR transfectant DBS43, which was made usingof a V2V2 TCR Transfectant Lacking NKG2D
cDNA encoding the TCR from DG.SF13, as effector cellsWe examined by flow cytometry the expression of the
in an IL-2 release assay. We compared the responsesNK cell activating receptor, NKG2D, in eight  T cell
of these two effector cell populations to the nonpeptideclones. All eight T cell clones we tested expressed cell
alkylamine antigen sec-butylamine using either C1Rsurface NKG2D (data not shown), confirming a previous
MICA or C1R mock transfectant cells as accessory cells.report (Bauer et al., 1999). Here, we show that DG.SF13,
At limiting antigen dilution, neither effector populationa V2V2 T cell clone raised against an extract of M.
released IL-2. Whereas the NKG2D DBS43 recognizedtuberculosis (Tanaka et al., 1995), expressed surface
antigen equally well in the presence of either C1R MICANKG2D. In contrast, the V2V2 TCR transfectant
or C1R mock accessory cells (Figure 4B, left), theDBS43 did not express NKG2D (Figure 4A), indicating
NKG2D DG.SF13 V2V2 T cell clone showed en-that cell surface expression of the V2V2 TCR could
be dissociated from the expression of NKG2D. hanced reactivity to antigen when C1R MICA rather than
MICA-NKG2D Interaction in Human V2V2 T Cells
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Figure 4. Expression of NKG2D on a  T Cell Clone and Its  TCR Transfectant
Anti-NKG2D (5C6) was used to stain the V2V2 T cell clone DG.SF13 and the V2V2 TCR transfectant DBS43; surface expression was
analyzed by flow cytometry. There was no staining seen with isotype control mAb (A). Secretion of IL-2 by a V2V2 T cell clone and its TCR
transfectant. The TCR transfectant, DBS43, and the original T cell clone, DG.SF13, from which DBS43 was made, were stimulated with sec-
butylamine using the C1R MICA transfectant (closed squares) or the C1R mock transfectant (open squares) as accessory cells. Maximum IL-2
release, as assessed by exposure to PMA and ionomycin in the absence of antigen, were 18,736 and 80,498 (cpm) for DG.SF13 and DBS43,
respectively (B).
C1R mock was used as an accessory cell population tween inhibitory NKG2A receptors on  T cells and
MHC class I on infected targets. Thus, the process of(Figure 4B, right). This experiment shows that the
V2V2 TCR can recognize antigen in the absence of acute bacterial infection induced the cell surface ex-
pression of MICA on DC and upregulated MICA expres-NKG2D and MICA. Collectively, these results provide
strong evidence that the NKG2D-MICA interaction sion on epithelial cell lines, thus potentially exposing
these cells to recognition by effector cells bearingserves to augment V2V2 TCR-mediated recognition
of antigen. NKG2D, the receptor for MICA.
MICA expression also was found in a supraclavicular
lymph node, detected by immunohistochemical stainingInduction of Cell Surface MICA Expression
using anti-MICA/B mAb, in one of three patients withby M. tuberculosis Infection
disseminated M. tuberculosis (Figure 5C, top). IsotypeSome intestinal epithelial cells in vivo constitutively ex-
control Ig did not stain the following section of the samepress cell surface MICA, but such expression can be
tissue (Figure 5C, bottom). The cells staining positiveinduced on other cells by a stressful stimulus such as
for MICA were dendritic in appearance (Figure 5C, inset).heat shock. To determine if bacterial infection could
Lymph nodes from 15 uninfected patients did not ex-induce cell surface expression of MICA, we infected
press MICA (data not shown). These results suggest thatmonocyte-derived dendritic cells (DC) with M. tubercu-
bacterial infection may induce cell surface expression oflosis H37Ra and analyzed the expression of surface
MICA in vivo.MICA and, for comparison, MHC class I, by flow cytome-
try 24 hr postinfection. Whereas mock-infected DC ex-
pressed little surface MICA, 29% of the M. tuberculosis- Role of MICA in Preferential Cytolysis
of M. tuberculosis-Infected Targetsinfected DC upregulated cell surface MICA expression
by 17-fold (mean fluorescence intensity (MFI) 	 282), as To determine whether the enhanced expression of sur-
face MICA that accompanied bacterial infection corre-compared to mock-infected DC (MFI 	 16) (Figure 5A).
M. tuberculosis infection of two colonic epithelial carci- lated with increased susceptibility to cytolysis, we used
M. tuberculosis-infected or uninfected HuTu80 ornoma cell lines, HCT116, and HuTu80, increased the MFI
of cell surface MICA by 2.5-fold (Figure 5B). Infection of HCT116 cells as targets in a cytotoxicity assay with
V2V2 T cells as effectors. At an E:T of 30, lysis of M.epithelial cells with the extracellular bacteria E. coli or
Morganella morganii did not upregulate cell surface tuberculosis-infected targets was four times higher than
that of uninfected controls using either the V2V2 T cellMICA (data not shown). M. tuberculosis infection did
not downregulate but slightly upregulated the surface clone isoamyl 5.C7 (Figure 6A, a and b) or the antigen-
stimulated primary V2V2 T cell lines IPP-1 (Figure 6A,expression of MHC class I in both DC and epithelial cell
lines (Figures 5A and 5B). This means that preferential c and d) and SBA-1 (Figure 6A, e and f) as effector cells.
To determine if the MICA-NKG2D interaction contrib-lysis of infected cells by  T cells (see next section) is
unlikely to be explained by decreased interaction be- uted to the cytotoxic activity against infected targets by
Immunity
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Figure 5. Cell Surface Expression of MICA after M. tuberculosis Infection In Vitro and In Vivo
(A) Level of surface expression of MICA and MHC class I on dendritic cells after mock infection or 24 hr postinfection with M. tuberculosis.
(B) Level of surface expression of MICA and MHC class I on the epithelial cell lines, HCT116, and HuTu80 after mock infection or 24 hr
postinfection with M. tuberculosis.
(C) Expression of cell surface MICA detected by anti-MICA/B mAb 6D4 in the lymph node of an M. tuberculosis-infected patient, inset with
higher magnification, and the same tissue stained with isotype control mAb in the lower panel.
V2V2 T cells, we pretreated HCT116 target cells with (Cosman et al., 2001). These results suggest that en-
gagement of NKG2D by MICA enhances V2V2 T cell-anti-MICA/B mAbs (6D4) or with isotype control mAbs.
Anti-MICA/B blocked cytotoxicity by 19%. Inclusion of mediated lysis of infected cells.
anti-NKG2D mAb (1D11) but not isotype control mAbs
blocked cytotoxicity by 48% (Figure 6B). Discussion
To analyze further the role of MICA in V2V2 T cell-
mediated recognition of infected cells, we used DCs as The regulation of human peripheral blood V2V2 T cells
is poorly understood. Recent insights into this problemtargets in cytotoxicity assays. At an E:T of 30, lysis of
M. tuberculosis-infected DCs was 1.7-fold higher than have been gained by the discovery of the unique non-
peptide antigens recognized by this polyclonal yet uni-that of mock-infected DCs using a V2V2 T cell line
(SBA-2) as effector cells (Figure 7A). Addition of anti- formly reactive population of MHC- and CD1-unre-
stricted T cells. Isopentenyl pyrophosphate (Morita etMICA/B mAb (6D4) or anti-NKG2D mAb (1D11) but not
isotype control mAb blocked cytotoxicity of infected al., 1996) and alkylamine antigens such as iso-butylam-
ine (Bukowski et al., 1999) are secreted by bacteria andtargets by 25% and 51%, respectively (Figure 7B).
As expected, blockade of cytotoxic activity was only are recognized in a V2V2 TCR-dependent manner (Bu-
kowski et al., 1995). Thus, these antigens are most likelypartial, since lysis of M. tuberculosis-infected cells can
occur in our optimized in vitro assays even in the ab- the targets that trigger V2V2 T cells to mediate anti-
bacterial effector functions such as proliferation (De Li-sence of MICA expression. Anti-NKG2D blocked lysis
more efficiently than did anti-MICA. This is likely due bero et al., 1991), secretion of TNF- and IFN- (Garcia
et al., 1997), secretion of chemokines (Poccia et al.,to the fact that additional ligands for NKG2D, termed
ULBPs, have been identified and may be expressed 1999), mobilization of granulysin (Spada et al., 2000),
and cytotoxicity (Morita et al., 1995). However, thesealongside MICA on infected epithelial and DC targets
MICA-NKG2D Interaction in Human V2V2 T Cells
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Figure 6. Cytotoxic Lysis of M. tuberculosis-
Infected Targets
(A) Lysis of M. tuberculosis-infected (closed
squares) or uninfected (open squares)
HCT116 (a, c, and e) or HuTu80 (b, d, and
f) epithelial cells by the V2V2 T cell clone
isoamyl 5.C7, and V2V2 T cell lines IPP-1
and SBA-1.
(B) Blocking of lysis using 6D4 F(ab)2 (anti-
MICA/B) and 1D11 (anti-NKG2D) mAbs. E:T
was 30 and the percent specific lysis of M.
tuberculosis-infected HCT 116 cells was 31%
and considered to be 100% of maximum spe-
cific lysis.
target antigens are not foreign or even occult, since al., 1993) that are upregulated during infection, but most
 T cells lack CD28 expression (Lafont et al., 2000).isopentenyl pyrophosphate is found in every cell as an
intermediate of isoprenoid synthesis (Morita et al., 1999), Here, we describe an activating receptor-ligand interac-
tion, utilized by V2V2 T cells, that is functionally analo-and alkylamine antigens are found in up to millimolar
concentrations in human body fluids such as vaginal gous but not identical to the CD28-B7 interaction utilized
by  T cells. This NKG2D-MICA interaction also en-secretions, breast milk, amniotic fluid, and urine (Lich-
tenberger et al., 1991). In healthy humans, these alkylam- hances CD8  T cell-mediated responses to viral anti-
gens (Groh et al., 2001).ine antigens either originate from ingestion of foodstuffs
such as apples, wine, and tea that contain alkylamines In the absence of antigen, NKG2D V2V2 T cells
did not lyse MICA targets, showing that the NKG2D-(Bukowski et al., 1999), or from synthesis by commensal
enteric bacteria such as E. coli and Morganella (Proteus) MICA interaction is not sufficient to trigger V2V2 T cell-
mediated lysis. However, in the presence of nonpeptidemorganii (Ghenghesh and Drucker, 1989).
Since these nonpeptide antigens are ubiquitous, the antigens associated with bacterial infection, MICA tar-
get cells were more susceptible than MICA targets toquestion arises of why, in the absence of infection,
V2V2 T cells are not constantly proliferating to high lysis by V2V2 T cells (Figure 1A), and this lysis could
be blocked with anti-NKG2D and anti-MICA/B mAbsnumbers in vivo. One potential explanation is that in the
absence of infection, the ambient levels of antigen that (Figures 1C and 1D). This MICA-associated enhance-
ment of antigen-dependent effector activity mediatedoccur in vivo as a result of environmental exposure or
commensal bacterial metabolism are too low to trigger by V2V2 T cells was seen also when IL-2 and IFN-
release were measured (Figures 2 and 3). Neithereffector functions but perhaps high enough to keep
V2V2 T cells in a state of quiescent readiness, primed NKG2DV2V2 TCR transfectants nor NKG2DV2V2
T cells recognized MICA transfectants in the absenceand ready to become a first line of defense against
pathogenic or opportunistic bacteria that may then se- of antigen. Moreover, the NKG2D V2V2 TCR trans-
fectant released equivalent amounts of IL-2 in responsecrete these antigens at levels high enough to trigger
effector T cell function and attendant antibacterial ac- to nonpeptide antigens using either MICA or mock
transfectants as accessory cells (Figure 4), showing thattivity.
A complementary explanation for the apparent toler- the V2V2 TCR itself does not recognize MICA in these
experiments. Taken together, these data suggest that anance of V2V2 T cells to the ambient levels of antigen
in vivo is that these  T cells need an additional signal NKG2D-MICA interaction serves to enhance the V2V2
TCR-dependent reactivity to nonpeptide antigens andthat allows them to secrete cytokines, to proliferate, and
to become cytotoxic.  T cells have such an additional superantigens.
We consistently found that mAbs to NKG2D blockedsignal: the costimulatory receptor CD28. CD28 recog-
nizes CD80 (Gimmi et al., 1991) and CD86 (Freeman et cytolysis of infected targets more efficiently than did
Immunity
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Figure 7. A V2V2 T Cell-Mediated Lysis of
M. tuberculosis-Infected DCs
(A) Lysis of M. tuberculosis-infected (closed
squares) or uninfected (open squares) DCs
by the V2V2 T cell line SBA-2.
(B) Blocking of lysis using 6D4 (anti-MICA/B)
and 1D11 (anti-NKG2D) mAbs. E:T was 30,
the percent specific lysis of M. tuberculosis-
infected DCs was 26% and considered to be
100% of maximum specific lysis.
mAbs to MICA. A new observation that may explain this killing could be partially blocked by anti-NKG2D and
anti-MICA/B mAbs, suggesting that this stress-induceddifference is that a class of activating NKG2D ligands,
molecule could be recognized by NKG2D V2V2 Ttermed ULBPs (UL-16 binding proteins), are likely to be
cells (Figures 6B and 7B). Taken together, these dataexpressed on the surface of the colonic epithelial and
suggest that NKG2D present on V2V2 T cells acts asdendritic cell targets we used in the present study. These
a coreceptor that engages MICA, which is upregulatedcell surface, GPI-linked, MHC class I-related molecules
on infected targets, thereby enhancing the activatingstimulate NKG2D NK cells to secrete cytokines and
signal provided by the TCR in response to microbialchemokines and to become cytotoxic, and since V2V2
antigens expressed at the cell surface.T cells are NKG2D, it is likely that ULBPs will have
Thus, we speculate that in particular instances, theactivating effects on these T cells (Cosman et al., 2001).
induction of MICA expression on the surface of infectedThus, mAb blockade of NKG2D is expected to be more
cells represents a danger signal (Matzinger, 1998) thatinhibitory than mAb blockade of either MICA or the
mobilizes normally quiescent V2V2 T cells, primed byULBPs, since the latter two are NKG2D ligands. The
the presence of ambient levels of antigen, to proliferate,tissue distribution of these two NKG2D ligands has yet
to secrete cytokines, and to become cytotoxic, therebyto be fully studied, but differences and overlaps in the
mediating antibacterial effects in vivo.location of MICA/B and ULBPs may dictate their biologi-
cal functions.
Experimental ProceduresIn vivo, lymph node cells with dendritic morphology
from an M. tuberculosis-infected patient stained positive Cell Lines and MICA Transfection
for MICA (Figure 5C), whereas lymph node cells from HCT116 and HuTu80 are colonic epithelial carcinoma cell lines ob-
tained from ATCC. MICA cDNA transfectants of C1R and Daudiuninfected individuals did not. Detection of MICA cells
have been described (Groh et al., 1996). DG.EBV and CP.EBV (EBVin the lymph nodes of only one of three infected patients
transformed B cell lines) were derived by transformation with EBV.may reflect that the mAb used in this study may not
react with all allelic forms of MICA/B, a polymorphic PBMC
family of molecules. Also, infection-induced upregula- Human PBMC were isolated from random donor leukopacks as a
byproduct of plateletpheresis at the Dana Farber Cancer Institutetion of surface MICA may be limited to a subpopulation
and from fresh peripheral blood of healthy donors by Ficoll-Paqueof dendritic cells that are prominent only during certain
density centrifugation.stages of infection. M. tuberculosis infection in vitro
upregulated expression of cell surface MICA on infected Derivation of  T Cell Clones
epithelial and dendritic cells (Figures 5A and 5B) that PBMC were isolated from 40 ml of freshly collected peripheral blood
by density centrifugation. One million PBMC were stimulated withwere killed by V2V2 T cells (Figures 6A and 7A). The
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amine or phosphate antigens in a 24-well plate using RPMI 1640 a percentage of specific release: (experimental count per min –
spontaneous counts per min)/(maximum release – spontaneouswith 10% FBS. Fresh media containing 1 nM of rIL-2 was added on
days 3 and 7. Flow cytometry performed at day 10 showed that  counts per min) 
 100.
T cells expanded to 70%–80% of CD3 cells. Culture was continued
for another 2 weeks. The cultured PBMC (1
 107 cells) were reacted Cytokine Release Assays
with the mAbs BMA031 and OKT4 to remove  T cells and CD4 Stimulation of the  T cell clones or of the V2V2 TCR transfectant
T cells, respectively, by magnetic bead selection (Morita et al., 1991). was performed in a 96-well flat-bottom plate with 2 
 104 responder
The cells were cloned by limiting dilution in round-bottom 96-well cells per well in 0.2 ml. 5 
 104 mitomycin C-treated C1R MICA
plates in RPMI 1640 with 10% FBS, 1 nM rIL-2, and 1:2000 PHA-P. transfectant or C1R mock transfectant cells per well were used as
Irradiated (5 Gy) allogeneic PBMC (1 
 105) and EBV-transformed accessory cells. Half log dilutions of amine or phosphate antigens,
B cells (DG.EBV and CP.EBV each 2.5 
 104) were added to each or, as a positive control, the calcium ionophore, ionomycin (at 1 g/
well as feeder cells. The clones were maintained by periodic restimu- ml) plus 10 ng/ml PMA were used (Bukowski et al., 1995). Antigens
lation with PHA. 1–2 
 105 T cells per well were cultured with irradi- were present throughout the 24 hr assay period. After a 24 hr incuba-
ated (5 Gy) allogeneic PBMC (5 
 105) and EBV-transformed B cells tion, the supernatant was harvested and used at a final dilution of
(DG.EBV and CP.EBV each 2.5
 105) as feeders and PHA-P (1:4000) 1:8 to stimulate the growth of the IL-2-dependent HT-2 cell line. IL-2
in RPMI 1640 supplemented with rIL-2 (1–2 nM) in 24-well plates. release assays were performed in triplicate using 5 
 103 HT-2 cells
Sec-butylamine (SBA)- and isopentenyl pyrophosphate (IPP)-stimu- per well in 96-well flat-bottom plates. After 18 hr, the cells were
lated T cell lines were derived from freshly isolated PBMC stimulated pulsed with 3H thymidine (1 Ci/well), harvested at 24 hr, and
with their respective antigens in 24-well plates as described above. counted by liquid scintillation on a Betaplate system. The standard
After 17 days, analysis by flow cytometry showed that the SBA cell deviation of the triplicate determination was less than 10% of the
line (SBA-1 and SBA-2) was 90% V2 cells and the IPP cell line mean. Interferon- (IFN-) and tumor necrosis factor- (TNF-) re-
(IPP-1) was 96% V2. Cell lines were used in assays within 25 days lease were analyzed by ELISA (Pharmingen, San Diego, CA) after 24
after initial stimulation. hr of antigenic stimulation following the manufacturer’s instructions.
TCR Transfectant Flow Cytometry
DBS43, a V2V2 TCR transfectant, was made as described (Bukow- Flow cytometry was performed by single-color staining with specific
ski et al., 1995) by transfecting TCR J.RT3-T3.5 cells with cDNA mAbs using appropriate isotype-matched mAbs as controls. Poly-
made from DG.SF13, a V2V2 TCR  T cell clone obtained by clonal FITC-conjugated F(ab)2 goat anti-mouse IgG (Tago) was used
stimulation of synovial fluid mononuclear cells with a mycobacterial as a secondary antibody. Propidium iodide gating was used to elimi-
extract and cultured with RPMI 1640 containing 10% FBS. nate dead cells from the analysis.
Ab and Ag Reagents Infection of Dendritic Cells and Epithelial Cells
mAbs used were as follows: IgG controls (P3, UPC10) (Sigma, St. with M. tuberculosis
Louis, MO), pan TCR- (BMA031), pan TCR- (anti-TCR1), V1/ M. tuberculosis (H37Ra, obtained from American Type Culture Col-
J1 (TCS1), V2 (BB3), V2 (7A5), CD3 (SPV-T3b), CD4 (OKT4), and lection [ATCC]) was grown in 7H9 broth (Difco Laboratories, Detroit,
MHC class I (W6/32). The specificity of these mAbs is reviewed in MI) containing 10% albumin dextrose catalase (ADC) supplement
Porcelli et al. (1991). mAbs NKG2D (1D11 and 5C6) and MICA/B (Difco), 2% glycerol, and 0.05% Tween-80 (Sigma) up to an OD600
(6D4 and 6D4 F(ab)2) were used as previously described (Groh et of 1, corresponding to a bacterial concentration of 1 
 108 CFU/
al., 1996). Anti-NKG2A (Z199) was kindly provided by Dr. Lorenzo ml. Immature DCs were derived from the monocytes isolated from
Moretta, Genoa, Italy, and anti-CD94 (DX22) was kindly provided by leukopack cultured for 4 days in presence of GM-CSF (300 IU/ml)
Dr. Joe Phillips, DNAX, Palo Alto, CA. Polyclonal FITC-conjugated and IL-4 (200 IU/ml). At day 4, 5 
 105 DCs were seeded in each
F(ab)2 goat anti-mouse IgG was purchased from Tago (Burlingame, well in a six-well plate. At day 5, infection was performed with M.
CA). Ethyl-, n-propyl-, iso-propyl-, n-butyl-, iso-butyl-, sec-butyl-, tuberculosis for 4 hr at a multiplicity of infection (MOI) of 2000. After
and iso-amylamines were purchased from Sigma. One molar stock extensive washing with PBS, cells were incubated for 24 hr at 37C
solution of these alkylamines was brought to pH 7.4 with HCl and with complete media. Cells were harvested with a scraper as some
used in half-log dilutions as antigens. Isopentenyl pyrophosphate cells were adherent after infection. Exposure to heat-killed bacteria
(IPP) was purchased from Sigma and monoethyl phosphate was failed to induce cell-surface MICA expression. Aliquots were used
synthesized as described (Tanaka et al., 1994). Pamidronate (Aredia) for flow cytometric analysis of surface MICA and MHC class I ex-
was purchased from Novartis (Basel, Switzerland) and staphylococ- pression, and staining for bacterial infection. Infection efficiency
cal enterotoxin A (SEA) was purchased from ToxTech (Sarasota, was 40% and each cell was infected with four to seven bacteria.
FL). Phytohemagglutinin-P (PHA) was obtained from Difco (Detroit, Epithelial cells HCT116 and HuTu80 were seeded in a six-well
MI). Mycobacterial extract was prepared as previously described plate at a density of 5 
 104 cells per well. Adherent subconfluent
(Tanaka et al., 1994). monolayers were infected with M. tuberculosis for 4 hr at an MOI
of 2000. The infection efficiency was 40% for HCT116 cells and
50% for HuTu80 cells and each cell was infected with three toCytotoxicity Assay
five bacteria. Extracellular bacteria Morganella (Proteus) morganii,Cytotoxic activity was evaluated by performing the classical 51Cr-
strain 235 (obtained from National Collection of Type Cultures, Lon-release assay. In brief, 5 
 106 target cells were labeled with 200
don, UK), and Escherichia coli (obtained from ATCC, 25922) with aCi of 51Cr (NEN, Boston, MA) and incubated for 2–4 hr at 37C. In
wide range of MOI were used to infect HCT116 and HuTu80 cellsantibody blocking assays, anti-MICA/B or isotype control mAbs
for 2–12 hr. After extensive washing with PBS, cells were incubatedwere added to cells after radiolabeling and incubated on ice for 45
for 24 hr at 37C with complete media. Cells were harvested withmin and then washed three times. In some experiments, mAbs were
nonenzymatic cell dissociation solution. Aliquots were used for flowincluded throughout the 4 hr incubation period. The cells were then
cytometric analysis of surface MICA and MHC class I expressiondispensed at a concentration of 2 
 103 cells/well in 96-well V-bot-
and used as target cells for cytotoxicity assays.tom plates. Effector cells were exposed to anti-NKG2D mAbs on
ice for 45 min, washed three times, and dispensed at several E:T
ratios into wells containing target cells. Serially diluted nonpeptide Immunohistology
Serial cryostat sections from O.C.T. compound (Sakura Finetek USAantigens or superantigens, when used, were present throughout
the 4 hr assay period. Cultures were incubated at 37C for 4 hr, Inc., Torrance, CA) embedded, snap frozen tissue specimens were
air dried and fixed in cold acetone. Alternating (unfixed) sectionscentrifuged at 200 
 g for 3 min, and 30–50 l of supernatant was
analyzed for radioactivity using a Betaplate scintillation counter. were stained for AFB using the Kinyoun technique or immunostained
with mAb 6D4 (anti-MICA/B) and isotype-matched control Ig usingMaximum release was assessed by addition of lysis detergent, 2%
NP40. Spontaneous release of labeled target cells ranged from 3%– the Envision System (Dako Corporation, Carpinteria, CA) as de-
scribed by the manufacturer. This system uses a horseradish peroxi-10% of maximum release. The mean of triplicate was expressed as
Immunity
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dase labeled polymer conjugated to affinity pure goat anti-mouse De Maria, A., Ferrazin, A., Ferrini, S., Ciccone, E., Terragna, A., and
Moretta, L. (1992). Selective increase of a subset of T cell receptorIg as secondary reagent. Organisms in lymph node specimens were
identified as M. tuberculosis using Genprobe AMTB assays.  T lymphocytes in the peripheral blood of patients with human
immunodeficiency virus type 1 infection. J. Infect. Dis. 165, 917–919.
Acknowledgments Freeman, G.J., Gribben, J.G., Boussiotis, V.A., Ng, J.W., Restivo,
V.A., Jr., Lombard, L.A., Gray, G.S., and Nadler, L.M. (1993). Cloning
We thank Dr. Joe Phillips and Dr. Lorenzo Moretta for providing of B7-2: a CTLA-4 counter-receptor that costimulates human T cell
mAbs, Dr. Michael B. Brenner for helpful discussions, and Dr. Li- proliferation. Science 262, 909–911.
sheng Wang for help with ELISA. This research was supported by Garcia, V.E., Sieling, P.A., Gong, J., Barnes, P.F., Uyemura, K., Ta-
grants from the National Institutes of Health, the Arthritis Founda- naka, Y., Bloom, B.R., Morita, C.T., and Modlin, R.L. (1997). Single-
tion, the American College of Rheumatology, and the Howard cell cytokine analysis of gamma delta T cell responses to nonpeptide
Hughes Institute. mycobacterial antigens. J. Immunol. 159, 1328–1335.
Ghenghesh, K.S., and Drucker, D.B. (1989). Gas liquid chromatogra-
Received January 26, 2001; revised May 25, 2001.
phy of amines produced by the Enterobacteriaceae. Brazilian J.
Med. Biol. Res. 22, 653–665.
References
Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman,
A.S., Morimoto, C., and Nadler, L.M. (1991). B-cell surface antigenBalbi, B., Valle, M.T., Oddera, S., Giunti, D., Manca, F., Rossi, G.A.,
B7 provides a costimulatory signal that induces T cells to proliferateand Allegra, L. (1993). T-lymphocytes with  V2 antigen recep-
and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575–6579.tors are present in increased proportions in a fraction of patients
Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M., andwith tuberculosis or with sarcoidosis. Am. Rev. Respir. Dis. 148,
Spies, T. (1996). Cell stress-regulated human major histocompatibil-1685–1690.
ity complex class I gene expressed in gastrointestinal epithelium.Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J.H., Lanier, L.L.,
Proc. Natl. Acad. Sci. USA 93, 12445–12450.and Spies, T. (1999). Activation of NK cells and T cells by NKG2D,
Groh, V., Steinle, A., Bauer, S., and Spies, T. (1998). Recognition ofa receptor for stress-inducible MICA. Science 285, 727–729.
stress-induced MHC molecules by intestinal epithelial gammadeltaBertotto, A., Gerli, R., Spinozzi, F., Muscat, C., Scalise, F., Castel-
T cells. Science 279, 1737–1740.lucci, G., Sposito, M., Candio, F., and Vaccaro, R. (1993). Lympho-
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K.H., andcytes bearing the  T cell receptor in acute Brucella melitensis
Spies, T. (1999). Broad tumor-associated expression and recogni-infection. Eur. J. Immunol. 23, 1177–1180.
tion by tumor-derived gamma delta T cells of MICA and MICB. Proc.Braud, V.M., Allan, D.S., O’Callaghan, C.A., Soderstrom, K., D’An-
Natl. Acad. Sci. USA 96, 6879–6884.drea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H.,
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M.S., Riddell,et al. (1998). HLA-E binds to natural killer cell receptors CD94/
S.R., and Spies, T. (2001). Costimulation of CD8alphabeta T cellsNKG2A, B and C. Nature 391, 795–799.
by NKG2D via engagement by MIC induced on virus-infected cells.Brooks, A.G., Posch, P.E., Scorzelli, C.J., Borrego, F., and Coligan,
Nat. Immunol. 2, 255–260.J.E. (1997). NKG2A complexed with CD94 defines a novel inhibitory
Halary, F., Peyrat, M.A., Champagne, E., Lopez-Botet, M., Moretta,natural killer cell receptor. J. Exp. Med. 185, 795–800.
A., Moretta, L., Vie, H., Fournie, J.J., and Bonneville, M. (1997).Bukowski, J.F., Morita, C.T., Tanaka, Y., Bloom, B.R., Brenner, M.B.,
Control of self-reactive cytotoxic T lymphocytes expressing gammaand Band, H. (1995). V2V2 TCR-dependent recognition of non-
delta T cell receptors by natural killer inhibitory receptors. Eur. J.peptide antigens and Daudi cells analyzed by TCR gene transfer.
Immunol. 27, 2812–2821.J. Immunol. 154, 998–1006.
Hara, T., Mizuno, Y., Takaki, K., Takada, H., Akeda, H., Aoki, T.,Bukowski, J.F., Morita, C.T., and Brenner, M.B. (1999). Human
Nagata, M., Ueda, K., Matsuzaki, G., Yoshikai, Y., et al. (1992). Pre-gamma delta T cells recognize alkylamines derived from microbes,
dominant activation and expansion of V9-bearing  T cells in vivoedible plants, and tea: implications for innate immunity. Immunity
as well as in vitro in Salmonella infection. J. Clin. Invest. 90, 204–210.11, 57–65.
Karre, K., Ljunggren, H.G., Piontek, G., and Kiessling, R. (1986).Caldwell, C.W., Everett, E.D., McDonald, G., Yesus, Y.W., Roland,
Selective rejection of H-2-deficient lymphoma variants suggests al-W.E., and Huang, H.M. (1996). Apoptosis of / T cells in human
ternative immune defence strategy. Nature 319, 675–678.ehrlichiosis. Am. J. Clin. Pathol. 105, 640–646.
Kunzmann, V., Bauer, E., and Wilhelm, M. (1999). Gamma/delta T-cellCarena, I., Shamshiev, A., Donda, A., Colonna, M., and Libero, G.D.
stimulation by pamidronate. N. Engl. J. Med. 340, 737–738.(1997). Major histocompatibility complex class I molecules modulate
Kunzmann, V., Bauer, E., Feurle, J., Weissinger, F., Tony, H.P., andactivation threshold and early signaling of T cell antigen receptor-
Wilhelm, M. (2000). Stimulation of gammadelta T cells by aminobis-gamma/delta stimulated by nonpeptidic ligands. J. Exp. Med. 186,
phosphonates and induction of antiplasma cell activity in multiple1769–1774.
myeloma. Blood 96, 384–392.
Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., and Baltimore,
Lafont, V., Liautard, J., Gross, A., Liautard, J.P., and Favero, J.D. (1998). HIV-1 Nef protein protects infected primary cells against
(2000). Tumor necrosis factor-alpha production is differently regu-killing by cytotoxic T lymphocytes. Nature 391, 397–401.
lated in gamma delta and alpha beta human T lymphocytes. J. Biol.
Colonna, M., and Samaridis, J. (1995). Cloning of immunoglobulin-
Chem. 275, 19282–19287.
superfamily members associated with HLA-C and HLA-B recogni-
Lanier, L.L. (1998). NK cell receptors. Annu. Rev. Immunol. 16,tion by human natural killer cells. Science 268, 405–408.
359–393.
Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R.,
Li, H., Lebedeva, M.I., Liera, A.S., Fields, B.A., Brenner, M.B., andFanslow, W., Kubin, M., and Chalupny, N.J. (2001). ULBPs, novel
Mariuzza, R.A. (1998). Crystal structure of the V domain of a humanMHC class I-related molecules, bind to CMV glycoprotein UL16 and
 T cell antigen receptor. Nature 391, 502–506.stimulate NK cytotoxicity through the NKG2D receptor. Immunity
14, 123–133. Lichtenberger, L.M., Gardner, J.W., Barreto, J.C., and Morriss, F.H.,
Jr. (1991). Evidence for a role of volatile amines in the developmentDas, H., Wang, L., Kamath, A., and Bukowski, J.F. (2001). V2V2
of neonatal hypergastrinemia. J. Pediatr. Gastroenterol. Nutr. 13,T cell receptor-mediated recognition of aminobisphosphonates.
342–346.Blood, in press.
Matzinger, P. (1998). An innate sense of danger. Semin. Immunol.De Libero, G., Casorati, G., Giachino, C., Carbonara, C., Migone,
10, 399–415.N., Matzinger, P., and Lanzavecchia, A. (1991). Selection by two
powerful antigens may account for the presence of the major popu- Miyagawa, F., Tanaka, Y., Yamashita, S., and Minato, N. (2001).
Essential requirement of antigen presentation by monocyte lineagelation of human peripheral / T cells. J. Exp. Med. 173, 1311–1322.
MICA-NKG2D Interaction in Human V2V2 T Cells
93
cells for the activation of primary human gammadelta T cells by
aminobisphosphonate antigen. J. Immunol. 166, 5508–5514.
Morita, C.T., Verma, S., Aparicio, P., Martinez-A., C., Spits, H., and
Brenner, M.B. (1991). Functionally distinct subsets of human / T
cells. Eur. J. Immunol. 21, 2999–3007.
Morita, C.T., Beckman, E.M., Bukowski, J.F., Tanaka, Y., Band, H.,
Bloom, B.R., Golan, D.E., and Brenner, M.B. (1995). Direct presenta-
tion of nonpeptide prenyl pyrophosphate antigens to human  T
cells. Immunity 3, 495–507.
Morita, C.T., Tanaka, Y., Bloom, B.R., and Brenner, M.B. (1996).
Direct presentation of non-peptide prenyl pyrophosphate antigens
to human  T cells. Res. Immunol. 147, 347–353.
Morita, C.T., Lee, H.K., Leslie, D.S., Tanaka, Y., Bukowski, J.F., and
Marker-Hermann, E. (1999). Recognition of nonpeptide prenyl pyro-
phosphate antigens by human gammadelta T cells. Microbes. Infect.
1, 175–186.
Munk, M.E., Gatrill, A.J., and Kaufmann, S.H.E. (1990). Target cell
lysis and IL-2 secretion by / T lymphocytes after activation with
bacteria. J. Immunol. 145, 2434–2439.
Perera, M.K., Carter, R., Goonewardene, R., and Mendis, K.N. (1994).
Transient increase in circulating / T cells during Plasmodium vivax
malarial paroxysms. J. Exp. Med. 179, 311–315.
Phillips, J.H., Gumperz, J.E., Parham, P., and Lanier, L.L. (1995).
Superantigen-dependent, cell-mediated cytotoxicity inhibited by
MHC class I receptors on T lymphocytes. Science 268, 403–405.
Poccia, F., Battistini, L., Cipriani, B., Mancino, G., Martini, F.,
Gougeon, M.L., and Colizzi, V. (1999). Phosphoantigen-reactive
Vgamma9Vdelta2 T lymphocytes suppress in vitro human immuno-
deficiency virus type 1 replication by cell-released antiviral factors
including CC chemokines. J. Infect. Dis. 180, 858–861.
Porcelli, S., Brenner, M.B., and Band, H. (1991). Biology of the human
 T-cell receptor. Immunol. Rev. 120, 137–183.
Raziuddin, S., Telmasani, A.W., El-Awad, M.E., Al-Amari, O., and Al-
Janadi, M. (1992).  T cells and the immune response in visceral
leishmaniasis. Eur. J. Immunol. 22, 1143–1148.
Rust, C.J.J., Verreck, F., Vietor, H., and Koning, F. (1990). Specific
recognition of staphylococcal enterotoxin A by human T cells bear-
ing receptors with the V9 region. Nature 346, 572–574.
Scalise, F., Gerli, R., Castellucci, G., Spinozzi, F., Fabietti, G.M.,
Crupi, S., Sensi, L., Britta, R., Vaccaro, R., and Bertotto, A. (1992).
Lymphocytes bearing the  T-cell receptor in acute toxoplasmosis.
Immunology 76, 668–670.
Schild, H., Mavaddat, N., Litzenberger, C., Ehrich, E.W., Davis, M.M.,
Bluestone, J.A., Matis, L., Draper, R.K., and Chien, Y.-h. (1994). The
nature of major histocompatibility complex recognition by  T cells.
Cell 76, 29–37.
Spada, F.M., Grant, E.P., Peters, P.J., Sugita, M., Melian, A., Leslie,
D.S., Lee, H.K., van Donselaar, E., Hanson, D.A., Krensky, A.M., et
al. (2000). Self-recognition of CD1 by gamma/delta T cells: implica-
tions for innate immunity. J. Exp. Med. 191, 937–948.
Sumida, T., Maeda, T., Takahashi, H., Yoshida, S., Yonaha, F., Saka-
moto, A., Tomioka, H., Koike, T., and Yoshida, S. (1992). Predominant
expansion of V9/V2 T cells in a tularemia patient. Infect. Immun.
60, 2554–2558.
Tanaka, Y., Sano, S., Nieves, E., De Libero, G., Roca, D., Modlin,
R.L., Brenner, M.B., Bloom, B.R., and Morita, C.T. (1994). Nonpeptide
ligands for human  T cells. Proc. Natl. Acad. Sci. USA 91, 8175–
8179.
Tanaka, Y., Morita, C.T., Tanaka, Y., Nieves, E., Brenner, M.B., and
Bloom, B.R. (1995). Natural and synthetic non-peptide antigens rec-
ognized by human  T cells. Nature 375, 155–158.
Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M.S.,
Vitale, M., Bottino, C., Moretta, L., Moretta, A., and Long, E.O. (1995).
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-
related molecules with diversity in both the extra- and intracellular
domains. Immunity 2, 439–449.
Wu, J., Song, Y., Bakker, A.B., Bauer, S., Spies, T., Lanier, L.L., and
Phillips, J.H. (1999). An activating immunoreceptor complex formed
by NKG2D and DAP10. Science 285, 730–732.
